123 related articles for article (PubMed ID: 36788478)
21. PROGRESSION OF RETINAL ISCHEMIA IN A CASE OF MACULAR TELANGIECTASIA TYPE 1 AFTER RANIBIZUMAB INJECTION: OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FINDINGS.
Lorusso M; Zito R; Nikolopoulou E; Micelli Ferrari L; Cicinelli MV; Querques G; Micelli Ferrari T
Retin Cases Brief Rep; 2020; 14(4):372-376. PubMed ID: 29443804
[TBL] [Abstract][Full Text] [Related]
22. Retinal ganglion cells thinning in eyes with nonproliferative idiopathic macular telangiectasia type 2A.
Chhablani J; Rao HB; Begum VU; Jonnadulla GB; Goud A; Barteselli G
Invest Ophthalmol Vis Sci; 2015 Feb; 56(2):1416-22. PubMed ID: 25655800
[TBL] [Abstract][Full Text] [Related]
23. Macular Dystrophy with Bilateral Macular Telangiectasia Related to the CYP2U1 Pathogenic Variant Assessed with Multimodal Imaging Including OCT-Angiography.
El Matri K; Falfoul Y; Habibi I; Chebil A; Schorderet D; El Matri L
Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828401
[TBL] [Abstract][Full Text] [Related]
24. OUTER FOVEAL DEFECTS IN TYPE-2 MACULAR TELANGIECTASIA.
Chandran K; Giridhar A; Gayathri MS; Antison M; Gopalakrishnan M; Sivaprasad S
Retina; 2023 Jan; 43(1):111-119. PubMed ID: 36542082
[TBL] [Abstract][Full Text] [Related]
25. Spectral domain OCT features in type 2 macular telangiectasia (type 2 MacTel): its relevance with clinical staging and visual acuity.
Venkatesh R; Reddy NG; Mishra P; Agrawal S; Mutalik D; Yadav NK; Chhablani J
Int J Retina Vitreous; 2022 Apr; 8(1):26. PubMed ID: 35382904
[TBL] [Abstract][Full Text] [Related]
26. FLUORESCENCE LIFETIME PATTERNS IN MACULAR TELANGIECTASIA TYPE 2.
Solberg Y; Dysli C; Wolf S; Zinkernagel MS
Retina; 2020 Jan; 40(1):99-108. PubMed ID: 30664123
[TBL] [Abstract][Full Text] [Related]
27. Does size of telangiectasia on optical coherence tomography angiography influence vision in eyes with type 2 macular telangiectasia?
Kelkar AS; Kelkar JA; Tidke S; Agarwal A; Bolisetty M; Kelkar S
Indian J Ophthalmol; 2021 Dec; 69(12):3570-3576. PubMed ID: 34826997
[TBL] [Abstract][Full Text] [Related]
28. CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.
Matet A; Yzer S; Chew EY; Daruich A; Behar-Cohen F; Spaide RF
Retina; 2018 Jan; 38 Suppl 1(Suppl 1):S67-S78. PubMed ID: 29016451
[TBL] [Abstract][Full Text] [Related]
29. Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2.
Clemons TE; Gillies MC; Chew EY; Bird AC; Peto T; Figueroa MJ; Harrington MW;
Ophthalmic Epidemiol; 2010; 17(1):66-73. PubMed ID: 20100102
[TBL] [Abstract][Full Text] [Related]
30. Demographic features of idiopathic macular telangiectasia in Japanese patients.
Maruko I; Iida T; Sugano Y; Ojima A; Oyamada H; Sekiryu T
Jpn J Ophthalmol; 2012 Mar; 56(2):152-8. PubMed ID: 22219035
[TBL] [Abstract][Full Text] [Related]
31. Fundus Autofluorescence Imaging in Macular Telangiectasia Type 2: MacTel Study Report Number 9.
Pauleikhoff L; Heeren TFC; Gliem M; Lim E; Pauleikhoff D; Holz FG; Clemons T; Balaskas K; ; Egan CA; Charbel Issa P
Am J Ophthalmol; 2021 Aug; 228():27-34. PubMed ID: 33775659
[TBL] [Abstract][Full Text] [Related]
32. Functional relevance of macular telangiectasia (MacTel) area on multicolour imaging in type 2 MacTel.
Venkatesh R; Reddy NG; Agrawal S; Pereira A; Mutalik D; Mishra P; Yadav NK; Chhablani J
Eur J Ophthalmol; 2022 Jul; 32(4):2368-2374. PubMed ID: 34488467
[TBL] [Abstract][Full Text] [Related]
33. Macular telangiectasia with bilateral obliterated capillaries: a case report.
Samadi M; Azarkish A; Riazi-Esfahani H; Mahmoudi A; Ebrahimiadib N
J Med Case Rep; 2022 Oct; 16(1):372. PubMed ID: 36224668
[TBL] [Abstract][Full Text] [Related]
34. Fluorescence Lifetime Imaging Ophthalmoscopy: A Novel Way to Assess Macular Telangiectasia Type 2.
Sauer L; Gensure RH; Hammer M; Bernstein PS
Ophthalmol Retina; 2018 Jun; 2(6):587-598. PubMed ID: 30116796
[TBL] [Abstract][Full Text] [Related]
35. Is Type 2 Macular Telangiectasia a Bilateral and Symmetrical Disease Entity?
Venkatesh R; Nahata H; Reddy NG; Mishra P; Mangla R; Yadav NK; Chhablani J
J Curr Ophthalmol; 2022; 34(4):428-435. PubMed ID: 37180535
[TBL] [Abstract][Full Text] [Related]
36. Radial Hemorrhage in Henle Layer in Macular Telangiectasia Type 2.
Au A; Hou K; Baumal CR; Sarraf D
JAMA Ophthalmol; 2018 Oct; 136(10):1182-1185. PubMed ID: 30054619
[TBL] [Abstract][Full Text] [Related]
37. MACULAR TELANGIECTASIA TYPE 2: Acircularity Index and Quantitative Assessment of Foveal Avascular Zone Using Optical Coherence Tomography Angiography.
Ersoz MG; Hocaoglu M; Sayman Muslubas I; Arf S; Karacorlu M
Retina; 2020 Jun; 40(6):1132-1139. PubMed ID: 30893277
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of cystoid spaces in type 2 idiopathic macular telangiectasia on spectral domain optical coherence tomography images.
Oh JH; Oh J; Togloom A; Kim SW; Huh K
Retina; 2014 Jun; 34(6):1123-31. PubMed ID: 24240556
[TBL] [Abstract][Full Text] [Related]
39. Tamoxifen retinopathy and macular telangiectasia: A comparative case series.
Venkatesh R; Sharief S; Jayadev C; Reddy NG; Mangla R; Agrawal R; Yadav NK; Chhablani J
Eur J Ophthalmol; 2022 Nov; ():11206721221142637. PubMed ID: 36437624
[TBL] [Abstract][Full Text] [Related]
40. Idiopathic macular telangiectasia type 2: A six-year study with multimodal imaging of a presumed unilateral case.
Zarei M; Mazloumi M; Karkhaneh R; Roohipoor R
J Curr Ophthalmol; 2018 Dec; 30(4):368-373. PubMed ID: 30555973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
